Determinants of response to inhaled extrafine triple therapy in asthma: analyses of TRIMARAN and TRIGGER

Abstract Background A number of single-inhaler triple therapies are being developed for asthma, including the extrafine formulation of beclometasone dipropionate (BDP), formoterol fumarate (FF), and glycopyrronium (G). Given asthma is a heterogenous disease, we investigated whether the clinical resp...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Dave Singh, Johann Christian Virchow, Giorgio Walter Canonica, Andrea Vele, Maxim Kots, George Georges, Alberto Papi
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2020-10-01
Saila:	Respiratory Research
Gaiak:	Asthma Pharmacotherapy Long-acting β2-agonists Long-acting muscarinic antagonists Inhaled corticosteroids Subgroup analyses
Sarrera elektronikoa:	http://link.springer.com/article/10.1186/s12931-020-01558-y
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!